Bupivacaine

Generic Name
Bupivacaine
Brand Names
Exparel, Kenalog, Marbeta, Marcaine, Marcaine With Epinephrine, Marvona Suik, P-Care M, P-Care MG, P-care, Posimir, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Sensorcaine, Sensorcaine With Epinephrine, Vivacaine, Xaracoll, Exparel liposomal
Drug Type
Small Molecule
Chemical Formula
C18H28N2O
CAS Number
38396-39-3
Unique Ingredient Identifier
Y8335394RO
Background

Bupivacaine is a widely used local anesthetic agent.

Indication

As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.

Bupivacaine, in liposome suspension, is indicated in patients aged 6 years and older for single-dose infiltration to produce postsurgical local analgesia. In adults, it is also indicated as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia.

Bupivacaine, in combination with meloxicam, is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.

Bupivacaine, alone or in combination with epinephrine, is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations are recommended for each type of block indicated to produce local or regional anesthesia or analgesia. Finally, its use is not indicated in all blocks given clinically significant risks associated with use.

Associated Conditions
Acute Gouty Arthritis, Adrenocortical Insufficiency, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Berylliosis, Bullous dermatitis herpetiformis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Dermatomyositis (DM), Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Hemolytic Anemia, Hypercalcemia caused by Cancer, Keloids Scars, Leukemias, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Ocular Inflammation, Ophthalmia, Sympathetic, Osteoarthritis (OA), Pain, Labor, Polymyositis, Postoperative pain, Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Regional Enteritis, Rheumatoid Arthritis, Secondary thrombocytopenia, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Trichinosis, Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Acute Bursitis, Acute Idiopathic Nephrotic Syndrome, Acute Lupus Erythematosus, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute nonspecific tenosynovitis, Cystic tumors of aponeurosis, Cystic tumors of tendon, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Inflammatory lesions of granuloma annulare, Inflammatory lesions of lichen planus, Inflammatory lesions of lichen simplex, Non-suppurative Thyroiditis, Permphigus, Severe Allergic Reactions
Associated Therapies
General Anesthesia, Local Anaesthesia therapy, Regional nerve block therapy

Dexmedetomidine Versus Clonidine for Transversus Abdominis Plane Block in Patients Undergoing Elective Caesarean Section

First Posted Date
2018-12-10
Last Posted Date
2020-08-05
Lead Sponsor
Aswan University Hospital
Target Recruit Count
150
Registration Number
NCT03770013
Locations
🇪🇬

Aswan University, Aswan, Egypt

EXPAREL for Minimally Invasive Supracervical Hysterectomies

Phase 4
Completed
Conditions
Interventions
First Posted Date
2018-12-07
Last Posted Date
2024-01-09
Lead Sponsor
Maimonides Medical Center
Target Recruit Count
60
Registration Number
NCT03769714
Locations
🇺🇸

Maimonides Medical Center, Brooklyn, New York, United States

Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section

First Posted Date
2018-12-07
Last Posted Date
2020-08-05
Lead Sponsor
Aswan University Hospital
Target Recruit Count
120
Registration Number
NCT03767920
Locations
🇪🇬

Aswan University, Aswan, Egypt

Regional Anesthesia to Reduce Opioid Use Following Functional Endoscopic Sinus Surgery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2018-11-29
Last Posted Date
2022-08-31
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
46
Registration Number
NCT03757715
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Erector Spinae Plane Block For Lumbar Disc Hernia Repair

First Posted Date
2018-11-16
Last Posted Date
2020-02-05
Lead Sponsor
Kocaeli University
Target Recruit Count
60
Registration Number
NCT03744689
Locations
🇹🇷

Kocaeli University, Kocaeli, Turkey

Spinal Anesthesia in Caesarean Section

First Posted Date
2018-11-16
Last Posted Date
2021-07-21
Lead Sponsor
Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
Target Recruit Count
250
Registration Number
NCT03743870
Locations
🇮🇹

"G. Rodolico" Presidium of the Azienda Ospedaliero Universitaria "Policlinico-Vittorio Emanuele", Catania, Italy

Exparel for Total Shoulder Pain

Phase 2
Not yet recruiting
Conditions
Interventions
First Posted Date
2018-11-13
Last Posted Date
2019-07-16
Lead Sponsor
University of South Florida
Target Recruit Count
60
Registration Number
NCT03739021

Liposomal Bupivacaine in Rotator Cuff Repair

Phase 4
Completed
Conditions
Interventions
First Posted Date
2018-11-13
Last Posted Date
2024-05-16
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
64
Registration Number
NCT03738696
Locations
🇺🇸

UAB Hospital-Highlands, Birmingham, Alabama, United States

Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy

First Posted Date
2018-11-09
Last Posted Date
2024-05-24
Lead Sponsor
Milton S. Hershey Medical Center
Target Recruit Count
40
Registration Number
NCT03737292
Locations
🇺🇸

Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 2.5ml of Bupivacaine 0.25% Plus Fentanyl 8 mcg/ml

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-11-08
Last Posted Date
2019-11-08
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
20
Registration Number
NCT03735771
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath